Literature DB >> 12846833

Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes.

Esther Velázquez1, Juan M Ruiz-Albusac, Enrique Blázquez.   

Abstract

Glucagon-like peptide-2 (GLP-2) is a potent intestinotrophic/satiety hormone that acts through a G protein-coupled receptor. To determine whether or not GLP-2 has any effect on cellular proliferation on neural cells, we examined the effects of this peptide on cultured astrocytes from rat cerebral cortex. The expression of the GLP-2 receptor gene in both cerebral cortex and astrocytes was determined by RT-PCR and Southern blotting. Also, cells responded to GLP-2, producing cAMP in a dose-dependent manner (EC50 = 0.86 nm). GLP-2 also stimulated the DNA synthesis rate in rat astrocytes. When proliferation was assessed by measuring [3H]thymidine incorporation into DNA or staining cells with crystal violet, GLP-2 produced a dose-dependent increase in both parameters. Similarly, when the numbers of cells in different phases of the cell cycle were measured by flow cytometry, a dose-dependent decrease in those in the G0-G1 phase and an increase in those in the S and G2-M phases were observed after 24 h incubation with GLP-2. By contrast, the number of hypodiploid cells was not affected during the experimental time. Also, GLP-2 produced a significant increase in the mRNAs of c-fos and c-jun when gene expression was determined by Northern blotting. These results suggest that GLP-2 directly stimulates the proliferation of rat astrocytes; this may open new insights in the physiological role of this novel neuropeptide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846833     DOI: 10.1046/j.1432-1033.2003.03677.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  The expression and role of stromal cell-derived factor-1alpha-CXCR4 axis in human dental pulp.

Authors:  Long Jiang; Ya-Qin Zhu; Rong Du; Ying-Xin Gu; Lie Xia; Feng Qin; Helena H Ritchie
Journal:  J Endod       Date:  2008-08       Impact factor: 4.171

2.  Glucagon-like peptide-2 (GLP-2) modulates the cGMP signalling pathway by regulating the expression of the soluble guanylyl cyclase receptor subunits in cultured rat astrocytes.

Authors:  Esther Velázquez; Enrique Blázquez; Juan Miguel Ruiz-Albusac
Journal:  Mol Neurobiol       Date:  2012-07-18       Impact factor: 5.590

Review 3.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

4.  Glucagon-like peptide 2 induces vasoactive intestinal polypeptide expression in enteric neurons via phophatidylinositol 3-kinase-γ signaling.

Authors:  Elaine de Heuvel; Laurie Wallace; Keith A Sharkey; David L Sigalet
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-14       Impact factor: 4.310

5.  Synergistic effect of glucagon-like peptide 2 (GLP-2) and of key growth factors on the proliferation of cultured rat astrocytes. Evidence for reciprocal upregulation of the mRNAs for GLP-2 and IGF-I receptors.

Authors:  Esther Velázquez; Enrique Blázquez; Juan Miguel Ruiz-Albusac
Journal:  Mol Neurobiol       Date:  2009-08-13       Impact factor: 5.590

6.  Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.

Authors:  Daniela Ruggiero; Stefania Nappo; Teresa Nutile; Rossella Sorice; Francesco Talotta; Emilia Giorgio; Celine Bellenguez; Anne-Louise Leutenegger; Giovanna L Liguori; Marina Ciullo
Journal:  PLoS Genet       Date:  2015-01-28       Impact factor: 5.917

Review 7.  Tackling dipeptidyl peptidase IV in neurological disorders.

Authors:  Ghaith Al-Badri; Gian Marco Leggio; Giuseppe Musumeci; Rubina Marzagalli; Filippo Drago; Alessandro Castorina
Journal:  Neural Regen Res       Date:  2018-01       Impact factor: 5.135

8.  Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin.

Authors:  Sachie Sasaki-Hamada; Masaatsu Ikeda; Jun-Ichiro Oka
Journal:  Sci Rep       Date:  2019-09-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.